Home \ Antibodies \ Nectin-3, Mouse, mAb 103-A1, FITC
Catalog # HM1053F

Nectin-3, Mouse, mAb 103-A1, FITC

Please choose the quantity of items you wish to add to your cart…
Find distributor

The monoclonal antibody 103-A1 recognizes mouse nectin-3. Nectin-3 is a 83 kDa type I
transmembrane glycoprotein. Nectin, originally isolated as poliovirus receptor-related protein (PRR), is
a cell-cell adhesion molecule of the immunoglobulin supergene family. Nectins are calciumindependent
immunoglobulin-like cell-cell adhesion molecules consisting of four members, nectin 1-4.
Nectins homophilically and heterophilically trans-interact to form a variety of cell-cell junctions,
including cadherin-based adherens junctions in epithelial cells and fibroblasts in culture, synaptic
junctions in neurons, and Sertoli cell-spermatid junctions in testis, in cooperation with, or
independently of, cadherins. Both nectin-2 and nectin-3 are ubiquitously expressed, whereas nectin-1
is abundantly expressed in brain. Nectin-2 and -3 are expressed in cells where cadherin is not
expressed, such as blood cells and spermatids. All members of the nectin family have two or three
splice variants. For nectin-3, three isoforms exist: nectin-3α, -3β and -3g of which nectin-3α is the
largest. Nectin-3, also known as PRR3, is a transmembrane protein that is predominantly expressed
in testis and placental tissues as well in many cell lines. Nectin interacts in vivo with both long and
short isoforms of afadin, an actin binding protein, at cadherin-based cell-cell adherence junctions in
various tissues and cell lines. Furthermore, the ectodomains of nectin-3 and CD155 (Poliovirus
Receptor) have shown strong affinity to each other.
Injection of antibody 103-A1 into lumen of seminiferous tubules leads to disruption of the actin
filaments in Sertoli cells at the Sertoli-maturing spermatid ectoplasmic specialization and exfoliation of
maturing spermatids form the seminiferous epithelium.

Flow cytometry, Frozen sections, Functional studies, Immuno assays, Immuno fluorescence

Application Notes
IF: fixed in 2% paraformaldehyde in PBS optionally followed by methanol/aceton fixation (Ref 2-7).
FC: 1 μg per 1 x 106 cells.
FS: injection of 1 μg into lumen of seminiferous tubules.
IA: Indirect ELISA on 0.5 μg/ml mouse nectin-3 coated per well. Positive signal with 2 μg/ml antibody.
IF: Cells are fixed in 2 % paraformaldehyde in PBS, optionally followed by methanol/aceton fixation (Ref 1-6).

Dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50.

Positive Control
L-cells (A cultured line of C3H mouse fibroblasts)

Negative Control
Cells/tissues derived from nectin-3 knockout mouse (Ref 5).

Product type
Monoclonal antibodies
100 µg, 20 µg
0.2 ml (100 μg/ml) 0.2 μm protein G purified FITC conjugated antibody solution in PBS, containing 1% bovine serum albumin and 0.02% sodium azide.
Extracellular domain 50-400 aa of mouse Nectin-3 fused with IgG Fc (Ref.1).
Rat IgG2a
Cross reactivity
Human – No, Rat – No
Poliovirus receptor-related protein 3, Nectin cell adhesion molecule 3, CD113<br> - Gene name: Nectin3, Pvrl3
Storage and stability
Product should be stored at 4 °C. Under recommended storage conditions, product is stable for at least one year.
For research use only. Not for use in or on humans or animals or for diagnostics. It is the responsibility of the user to comply with all local/state and federal rules in the use of this product. Hycult Biotech is not responsible for any patent infringements that might result from the use or derivation of this product.
Infectious diseases

Calculate your ELISA data easily

With the ELISA calculator you can easily calculate ELISA data. Assayfit Pro helps to perform curve fitting. The calculator generates advanced reports, fit graph, fit parameters and goodness of fit are shown.

Latest Hycult Biotech news

  • New Human Complement Pathway Assays
    We are very proud of our newly developed human classical and alternative complement pathway assays. They are produced in response to a growing demand for quantitative investigation of complement inhibitors or regulators at lower sample dilutions. This development aims to address the issue of false negative results, enabling more accurate and reliable analysis of complement… Read more: New Human Complement Pathway Assays
  • Navigating the pitfalls in complement analysis
    Our colleague Erik Toonen shared his experience on how to analyze complement at the Complement-based Drug Development Summit in Boston in September 11-13th, 2023. He showed valuable insights on analyzing complements. For accurate complement analysis, it is important that not only the correct technique is used but also that pre-analytical sample handling is performed in… Read more: Navigating the pitfalls in complement analysis
  • NEW Human C3d ELISA
    We are happy to introduce our new ELISA (cat.# HK3017) designed to detect human C3d. What sets this assay apart is its utilization of a distinctive neo-epitope capture antibody that selectively targets a specific C3d region of the alpha chain, which is not available in other C3 variants. This way it specifically distinguishes C3d from native C3… Read more: NEW Human C3d ELISA
Contact us